IP Library › Granted Patent US 12,551,338
Granted Patent B2
US 12,551,338 · App. 18/061,388 · Granted Feb 17, 2026

Transcatheter pulmonic regenerative valve

Inventors: Hao Shang (Irvine, CA); Louis A. Campbell (Santa Ana, CA)
Assignee: Edwards Lifesciences Corporation
A61F2/2418A61F2/2433A61F2/2436A61L27/3633A61L27/54A61L31/041A61L31/148A61F2002/0081A61F2210/0004A61F2220/0008A61F2250/001A61F2250/0039A61F2250/0067A61L2430/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,551,338
App. No.
18/061,388
Granted
Feb 17, 2026
Kind
B2
Abstract

Artificial heart valves, their manufacture, and methods of use are described. Generally, artificial heart valves can be deployed to replace or supplement defective heart valves in a patient. These artificial heart valves can comprise a frame with an inner skirt and leaflets. These inner skirt and leaflets can be generated from regenerative tissue to allow integration of the tissue with the body of a patient, while the frame can be generated from bioabsorbable material to allow dissolution of the frame over time. This combination of materials may allow for the artificial valve to grow with a patient and avoid costly and potentially dangerous replacement for patients receiving artificial valves.

Claims (35)

1 . A method of implanting an artificial heart valve using a catheter comprising:

accessing the vascular system of a patient;

advancing a radially expandable artificial heart valve to the pulmonary artery, the aorta, or a heart annulus of the patient, wherein the artificial heart valve is in a radially collapsed configuration and comprises a frame having an inflow end portion defining an inflow end of the frame that is configured to receive antegrade blood flow into the artificial heart valve when implanted, and the frame also having an outflow end portion defining an outflow end of the frame opposite the inflow end of the frame, the prosthetic heart valve also comprising a leaflet structure positioned within the frame, an inner skirt positioned along an inner surface of the frame, wherein the frame comprises a bioabsorbable material, wherein the leaflet structure is constructed of a regenerative tissue, and the inner skirt is constructed of a second regenerative tissue, wherein the regenerative tissue and the second regenerative tissue are capable of being integrated into native tissue, wherein the leaflet structure comprises a plurality of leaflets, each leaflet comprising a body portion having a free outflow edge, two opposing upper tabs extending from opposite sides of the body portion, and two opposing lower tabs, each lower tab extending from the body portion adjacent to a respective upper tab, the lower tabs extending from the body portion at opposite ends of the free outflow edge, and wherein the artificial heart valve is mounted on a delivery apparatus; wherein the frame further comprises tissue engaging elements to allow fixation of the artificial heart valve to the wall of a blood vessel; wherein the tissue engaging elements is coated with a bioabsorbable glue to prevent the tissue engaging elements from expanding and allowing the artificial heart valve to be repositioned; and

delivering the radially expandable artificial heart valve to the pulmonary artery of the patient.

2 . The method of implanting an artificial heart valve of claim 1 , wherein access to the vascular system of a patient is accomplished percutaneously.

3 . The method of implanting an artificial heart valve of claim 1 , wherein access to the vascular system of a patient is accomplished by accessing the femoral vein.

4 . The method of implanting an artificial heart valve of claim 3 , wherein the advancing step is performed by way of the femoral vein, inferior vena cava, tricuspid valve, and right ventricle.

5 . The method of implanting an artificial heart valve of claim 1 , wherein the delivery apparatus is a catheter.

6 . The method of implanting an artificial heart valve of claim 5 , wherein the catheter is a balloon catheter comprising a balloon, wherein the balloon is deflated;

the radially expandable artificial heart valve is positioned over the balloon; and

the delivering step is accomplished by inflating the balloon, wherein the inflating balloon radially expands the radially expandable artificial heart valve.

7 . The method of implanting an artificial heart valve of claim 5 , wherein the catheter is a sheath catheter comprising an outer sleeve;

the radially expandable artificial heart valve is disposed in the outer sleeve; and

the delivering step is accomplished by retracting the outer sleeve, wherein the retracting sleeve allows the radially expandable artificial heart valve to expand.

8 . The method of implanting an artificial heart valve of claim 1 , wherein the bioabsorbable material is selected from the group consisting of: poly(L-lactide), poly(D-lactide), polyglycolide, poly (L-lactide-co-glycolide), polyhydroxyalkanoate, polysaccharides, proteins, polyesters, polyhydroxyalkanoates, polyalkelene esters, polyamides, polycaprolactone, polylactide-co-polycaprolactone, polyvinyl esters, polyamide esters, polyvinyl alcohols, modified derivatives of caprolactone polymers, polytrimethylene carbonate, polyacrylates, polyethylene glycol, hydrogels, photo-curable hydrogels, terminal dials, poly(L-lactide-co-trimethylene carbonate), polyhydroxybutyrate; polyhydroxyvalerate, poly-orthoesters, poly-anhydrides, polyiminocarbonate, and copolymers and combinations thereof.

9 . The method of implanting an artificial heart valve of claim 1 , wherein the frame further comprises a plurality of commissure window frames to allow attachment of the leaflet structure.

10 . The method of implanting an artificial heart valve of claim 9 , wherein the commissure window frames are constructed of a non-bioabsorbable material, and the frame is constructed of a bioabsorbable material.

11 . The method of implanting an artificial heart valve of claim 1 , wherein the leaflet structure and inner skirt are constructed of the same regenerative tissue.

12 . The method of implanting an artificial heart valve of claim 1 , wherein the lower tabs are folded about radially extending creases that extend radially from the opposite ends of the free outflow edge, such that a first portion of the lower tabs lies flat against the body portion of the respective leaflet, and the lower tabs are folded about axially extending creases such that a second portion of the lower tabs extends in a different plane than the first portion, wherein the radially extending creases and the axially extending creases are nonparallel.

13 . The method of implanting an artificial heart valve of claim 12 , wherein the second portion of each lower tab is sutured to a respective upper tab.

14 . The method of implanting an artificial heart valve of claim 1 , wherein the regenerative tissue and second regenerative tissue are selected from the group consisting of: polyglactin, collagen, and polyglycolic acid.

15 . The method of implanting an artificial heart valve of claim 14 , wherein the regenerative tissue further comprises extracellular matrix proteins selected from the group consisting of: hydroxyproline, vitronectin, fibronectin and collagen type I, collagen type III, collagen type IV, collagen VI, collagen XI, collagen XII, fibrillin I, tenascin, decorin, byglycan, versican, asporin, and combinations thereof.

16 . The method of implanting an artificial heart valve of claim 1 , wherein the inner skirt extends beyond at least one of the outflow end and inflow end of the frame and forms an outer skirt attached to an outer surface of the frame.

17 . The method of implanting an artificial heart valve of claim 1 , wherein the frame further comprises growth factors to promote integration of the regenerative tissue.

18 . The method of implanting an artificial heart valve of claim 1 , wherein an outer diameter of the inflow end portion of the frame is smaller than an outer diameter of the outflow end portion of the frame.

19 . The method of implanting an artificial heart valve of claim 1 , wherein the frame has a plurality of openings and portions of the leaflet structure protrude through the openings while the prosthetic valve is in the radially collapsed configuration.

20 . The method of implanting an artificial heart valve of claim 1 , wherein the frame is comprised of a combination of bioabsorbable and non-bioabsorbable materials.

21 . A method of implanting an artificial heart valve using a catheter comprising:

accessing the vascular system of a patient;

advancing a radially expandable artificial heart valve to the pulmonary artery, the aorta, or a heart annulus of the patient, wherein the artificial heart valve is in a radially collapsed configuration and comprises a frame having an inflow end portion defining an inflow end of the frame that is configured to receive antegrade blood flow into the artificial heart valve when implanted, and the frame also having an outflow end portion defining an outflow end of the frame opposite the inflow end of the frame, the prosthetic heart valve also comprising a leaflet structure positioned within the frame, an inner skirt positioned along an inner surface of the frame, wherein the leaflet structure is constructed of a regenerative tissue, and the inner skirt is constructed of a second regenerative tissue, wherein the regenerative tissue and the second regenerative tissue are capable of being integrated into native tissue, wherein the frame has a plurality of openings and portions of the leaflet structure protrude through the openings while the prosthetic valve is in the radially collapsed configuration, wherein the frame comprises a bioabsorbable material, and wherein the artificial heart valve is mounted on a delivery apparatus; wherein the frame further comprises tissue engaging elements to allow fixation of the artificial heart valve to the wall of a blood vessel; wherein the tissue engaging elements is coated with a bioabsorbable glue to prevent the tissue engaging elements from expanding and allowing the artificial heart valve to be repositioned; and

delivering the radially expandable artificial heart valve to the pulmonary artery of the patient.

22 . A method of implanting an artificial heart valve using a catheter comprising:

accessing the vascular system of a patient;

advancing a radially expandable artificial heart valve to the pulmonary artery, the aorta, or a heart annulus of the patient, wherein the artificial heart valve is in a radially collapsed configuration and comprises a frame having an inflow end portion defining an inflow end of the frame that is configured to receive antegrade blood flow into the artificial heart valve when implanted, and the frame also having an outflow end portion defining an outflow end of the frame opposite the inflow end of the frame, the prosthetic heart valve also comprising a leaflet structure positioned within the frame, an inner skirt positioned along an inner surface of the frame, wherein the leaflet structure is constructed of a regenerative tissue, and the inner skirt is constructed of a second regenerative tissue, wherein the regenerative tissue and the second regenerative tissue are capable of being integrated into native tissue, wherein the frame is comprised of a combination of bioabsorbable and non-bioabsorbable materials, and wherein the artificial heart valve is mounted on a delivery apparatus; wherein the frame further comprises tissue engaging elements to allow fixation of the artificial heart valve to the wall of a blood vessel; wherein the tissue engaging elements is coated with a bioabsorbable glue to prevent the tissue engaging elements from expanding and allowing the artificial heart valve to be repositioned; and

delivering the radially expandable artificial heart valve to the pulmonary artery of the patient.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2026
From: SHANG, HAO; CAMPBELL, LOUIS A.
To: EDWARDS LIFESCIENCES CORPORATION
Reel/Frame 073480/0460 →
Continuity (3)
Division 16666319 · Oct 28, 2019
Provisional Application 62754102 · Nov 1, 2018
Related Publication 20230147439A1 · May 11, 2023
References Cited (299)
US 2393580A · Weiskopf · 1946 [cited by applicant]
US 4120649A · Schechter · 1978 [cited by applicant]
US 4323358A · Lentz et al. · 1982 [cited by applicant]
US 4350492A · Wright et al. · 1982 [cited by applicant]
US 4372743A · Lane · 1983 [cited by applicant]
US 4378224A · Nimni et al. · 1983 [cited by applicant]
US 4402697A · Pollock et al. · 1983 [cited by applicant]
US 4405327A · Pollock · 1983 [cited by applicant]
US 4481009A · Nashef · 1984 [cited by applicant]
US 4553974A · Dewanjee · 1985 [cited by applicant]
US 4624822A · Arru et al. · 1986 [cited by applicant]
US 4647283A · Carpentier et al. · 1987 [cited by applicant]
US 4648881A · Carpentier et al. · 1987 [cited by applicant]
US 4758151A · Arru et al. · 1988 [cited by applicant]
US 4770665A · Nashef · 1988 [cited by applicant]
US 4776853A · Klement et al. · 1988 [cited by applicant]
US 4786287A · Nashef et al. · 1988 [cited by applicant]
US 4838888A · Nashef · 1989 [cited by applicant]
US 4865871A · Livesey et al. · 1989 [cited by applicant]
US 4885005A · Nashef et al. · 1989 [cited by applicant]
US 4958008A · Petite et al. · 1990 [cited by applicant]
US 4976733A · Girardot · 1990 [cited by applicant]
US 5002566A · Carpentier et al. · 1991 [cited by applicant]
US 5051401A · Sikes · 1991 [cited by applicant]
US 5080670A · Imamura et al. · 1992 [cited by applicant]
US 5094661A · Levy et al. · 1992 [cited by applicant]
US 5104405A · Nimni · 1992 [cited by applicant]
US 5116564A · Jansen et al. · 1992 [cited by applicant]
US 5147514A · Mechanic · 1992 [cited by applicant]
US 5154007A · Piunno et al. · 1992 [cited by applicant]
US 5200399A · Wettlaufer et al. · 1993 [cited by applicant]
US 5215541A · Nashef et al. · 1993 [cited by applicant]
US 5279612A · Eberhardt · 1994 [cited by applicant]
US 5329846A · Bonutti · 1994 [cited by applicant]
US 5397353A · Oliver et al. · 1995 [cited by applicant]
US 5437287A · Phillips et al. · 1995 [cited by applicant]
US 5447536A · Girardot et al. · 1995 [cited by applicant]
US 5460962A · Kemp · 1995 [cited by applicant]
US 5476516A · Seifter et al. · 1995 [cited by applicant]
US 5489297A · Duran · 1996 [cited by examiner]
US 5509932A · Keogh et al. · 1996 [cited by applicant]
US 5558875A · Wang · 1996 [cited by applicant]
US 5595571A · Jaffe et al. · 1997 [cited by applicant]
US 5613982A · Goldstein · 1997 [cited by applicant]
US 5645587A · Chanda et al. · 1997 [cited by applicant]
US 5674298A · Levy et al. · 1997 [cited by applicant]
US 5697972A · Kim et al. · 1997 [cited by applicant]
US 5713953A · Vallana et al. · 1998 [cited by applicant]
US 5720777A · Jaffe et al. · 1998 [cited by applicant]
US 5720894A · Neev et al. · 1998 [cited by applicant]
US 5733339A · Girardot et al. · 1998 [cited by applicant]
US 5746775A · Levy et al. · 1998 [cited by applicant]
US 5766520A · Bronshtein · 1998 [cited by applicant]
US 5769780A · Hata et al. · 1998 [cited by applicant]
US 5782914A · Schankereli · 1998 [cited by applicant]
US 5782931A · Yang et al. · 1998 [cited by applicant]
US 5843180A · Jaffe et al. · 1998 [cited by applicant]
US 5843181A · Jaffe et al. · 1998 [cited by applicant]
US 5855620A · Bishopric et al. · 1999 [cited by applicant]
US 5862806A · Cheung · 1999 [cited by applicant]
US 5873812A · Ciana et al. · 1999 [cited by applicant]
US 5899936A · Goldstein · 1999 [cited by applicant]
US 5911951A · Girardot et al. · 1999 [cited by applicant]
US 5919472A · Trescony et al. · 1999 [cited by applicant]
US 5921980A · Kim · 1999 [cited by applicant]
US 5931969A · Carpentier et al. · 1999 [cited by applicant]
US 5935168A · Yang et al. · 1999 [cited by applicant]
US 5945319A · Keogh · 1999 [cited by applicant]
US 5977153A · Camiener · 1999 [cited by applicant]
US 5993844A · Abraham et al. · 1999 [cited by applicant]
US 6008292A · Lee et al. · 1999 [cited by applicant]
US 6017741A · Keogh · 2000 [cited by applicant]
US 6093530A · McIlroy et al. · 2000 [cited by applicant]
US 6106555A · Yang · 2000 [cited by applicant]
US 6117979A · Hendriks et al. · 2000 [cited by applicant]
US 6121041A · Mirsch, II et al. · 2000 [cited by applicant]
US 6132472A · Bonutti · 2000 [cited by applicant]
US 6132473A · Williams et al. · 2000 [cited by applicant]
US 6132986A · Pathak et al. · 2000 [cited by applicant]
US 6156030A · Neev · 2000 [cited by applicant]
US 6156531A · Pathak et al. · 2000 [cited by applicant]
US 6165215A · Rottenberg et al. · 2000 [cited by applicant]
US 6166184A · Hendriks et al. · 2000 [cited by applicant]
US 6174331B1 · Moe et al. · 2001 [cited by applicant]
US 6177514B1 · Pathak et al. · 2001 [cited by applicant]
US 6190407B1 · Ogle et al. · 2001 [cited by applicant]
US 6193749B1 · Schroeder et al. · 2001 [cited by applicant]
US 6203755B1 · Odland · 2001 [cited by applicant]
US 6206917B1 · Williams et al. · 2001 [cited by applicant]
US 6210957B1 · Carpentier et al. · 2001 [cited by applicant]
US 6214054B1 · Cunanan et al. · 2001 [cited by applicant]
US 6214055B1 · Simionescu et al. · 2001 [cited by applicant]
US 6231608B1 · Stone · 2001 [cited by applicant]
US 6231614B1 · Yang · 2001 [cited by applicant]
US 6251579B1 · Moore et al. · 2001 [cited by applicant]
US 6254635B1 · Schroeder et al. · 2001 [cited by applicant]
US 6267786B1 · Stone · 2001 [cited by applicant]
US 6277555B1 · Duran et al. · 2001 [cited by applicant]
US 6287338B1 · Sarnowski et al. · 2001 [cited by applicant]
US 6293970B1 · Wolfinbarger, Jr. et al. · 2001 [cited by applicant]
US 6302909B1 · Ogle et al. · 2001 [cited by applicant]
US 6312474B1 · Francis et al. · 2001 [cited by applicant]
US 6322593B1 · Pathak et al. · 2001 [cited by applicant]
US 6328762B1 · Anderson et al. · 2001 [cited by applicant]
US 6334873B1 · Lane et al. · 2002 [cited by applicant]
US 6352708B1 · Duran et al. · 2002 [cited by applicant]
US 6364905B1 · Simpson et al. · 2002 [cited by applicant]
US 6375680B1 · Carlyle · 2002 [cited by applicant]
US 6383732B1 · Stone · 2002 [cited by applicant]
US 6391538B1 · Vyavahare et al. · 2002 [cited by applicant]
US 6394096B1 · Constantz · 2002 [cited by applicant]
US 6448076B2 · Dennis et al. · 2002 [cited by applicant]
US 6468660B2 · Ogle et al. · 2002 [cited by applicant]
US 6471723B1 · Ashworth et al. · 2002 [cited by applicant]
US 6479079B1 · Pathak et al. · 2002 [cited by applicant]
US 6482199B1 · Neev · 2002 [cited by applicant]
US 6506339B1 · Girardot et al. · 2003 [cited by applicant]
US 6509145B1 · Torrianni · 2003 [cited by applicant]
US 6534004B2 · Chen et al. · 2003 [cited by applicant]
US 6547827B2 · Carpentier et al. · 2003 [cited by applicant]
US 6561970B1 · Carpentier et al. · 2003 [cited by applicant]
US 6569200B2 · Wolfinbarger, Jr. et al. · 2003 [cited by applicant]
US 6582464B2 · Gabbay · 2003 [cited by applicant]
US 6589591B1 · Mansouri et al. · 2003 [cited by applicant]
US 6605667B1 · Badejo et al. · 2003 [cited by applicant]
US 6617142B2 · Keogh et al. · 2003 [cited by applicant]
US 6630001B2 · Duran et al. · 2003 [cited by applicant]
US 6652594B2 · Francis et al. · 2003 [cited by applicant]
US 6653062B1 · DePablo et al. · 2003 [cited by applicant]
US 6682559B2 · Myers et al. · 2004 [cited by applicant]
US 6696074B2 · Dai et al. · 2004 [cited by applicant]
US 6730118B2 · Spenser · 2004 [cited by examiner]
US 6734018B2 · Wolfinbarger, Jr. et al. · 2004 [cited by applicant]
US 6753181B2 · Atala · 2004 [cited by applicant]
US 6790229B1 · Berreklouw · 2004 [cited by applicant]
US 6797000B2 · Simpson et al. · 2004 [cited by applicant]
US 6872226B2 · Cali et al. · 2005 [cited by applicant]
US 6878168B2 · Carpentier et al. · 2005 [cited by applicant]
US 6908591B2 · MacPhee et al. · 2005 [cited by applicant]
US 6911043B2 · Myers et al. · 2005 [cited by applicant]
US 6919172B2 · DePablo et al. · 2005 [cited by applicant]
US 7008763B2 · Cheung · 2006 [cited by applicant]
US 7029434B2 · Carpentier et al. · 2006 [cited by applicant]
US 7037333B2 · Myers et al. · 2006 [cited by applicant]
US 7063726B2 · Crouch et al. · 2006 [cited by applicant]
US 7078163B2 · Torrianni · 2006 [cited by applicant]
US 7141064B2 · Scott et al. · 2006 [cited by applicant]
US 7143769B2 · Stoltz et al. · 2006 [cited by applicant]
US 7214344B2 · Carpentier et al. · 2007 [cited by applicant]
US 7238200B2 · Lee et al. · 2007 [cited by applicant]
US 7318998B2 · Goldstein et al. · 2008 [cited by applicant]
US 7338757B2 · Wolfinbarger, Jr. et al. · 2008 [cited by applicant]
US 7354749B2 · Fisher et al. · 2008 [cited by applicant]
US 7367969B2 · Stoltz et al. · 2008 [cited by applicant]
US RE40570E · Carpentier et al. · 2008 [cited by applicant]
US 7498565B2 · Silberberg et al. · 2009 [cited by applicant]
US 7579381B2 · Dove · 2009 [cited by applicant]
US 7594974B2 · Cali et al. · 2009 [cited by applicant]
US 7648676B2 · Mills et al. · 2010 [cited by applicant]
US 7682304B2 · Heyninck-Jantz et al. · 2010 [cited by applicant]
US 7914569B2 · Nguyen et al. · 2011 [cited by applicant]
US 7919112B2 · Pathak et al. · 2011 [cited by applicant]
US 7972376B1 · Dove et al. · 2011 [cited by applicant]
US 8007992B2 · Tian et al. · 2011 [cited by applicant]
US 8038708B2 · Case et al. · 2011 [cited by applicant]
US 8043450B2 · Cali et al. · 2011 [cited by applicant]
US 8075615B2 · Eberhardt et al. · 2011 [cited by applicant]
US 8105375B2 · Navia et al. · 2012 [cited by applicant]
US 8136218B2 · Millwee et al. · 2012 [cited by applicant]
US 8308797B2 · Paniagua et al. · 2012 [cited by applicant]
US 8361144B2 · Fish et al. · 2013 [cited by applicant]
US 8377143B2 · Hamby et al. · 2013 [cited by applicant]
US 8475827B2 · Hamby et al. · 2013 [cited by applicant]
US 9393110B2 · Levi · 2016 [cited by examiner]
US 10376359B2 · Essinger · 2019 [cited by examiner]
US 10433958B2 · Levi · 2019 [cited by examiner]
US 10433959B2 · Levi · 2019 [cited by examiner]
US 10478292B2 · Levi · 2019 [cited by examiner]
US 10537423B2 · Levi · 2020 [cited by examiner]
US 10729542B2 · Howard · 2020 [cited by examiner]
US 10729543B2 · Levi · 2020 [cited by examiner]
US 20010000804A1 · Goldstein et al. · 2001 [cited by applicant]
US 20010025196A1 · Chinn et al. · 2001 [cited by applicant]
US 20010027344A1 · Bonutti · 2001 [cited by applicant]
US 20010032024A1 · Cunanan et al. · 2001 [cited by applicant]
US 20010039450A1 · Pavcnik · 2001 [cited by examiner]
US 20010039459A1 · Stone · 2001 [cited by applicant]
US 20020001834A1 · Keogh et al. · 2002 [cited by applicant]
US 20020091441A1 · Guzik · 2002 [cited by applicant]
US 20020111532A1 · Pathak et al. · 2002 [cited by applicant]
US 20030035843A1 · Livesey et al. · 2003 [cited by applicant]
US 20030055496A1 · Cai · 2003 [cited by examiner]
US 20030125805A1 · Johnson et al. · 2003 [cited by applicant]
US 20030135284A1 · Crouch et al. · 2003 [cited by applicant]
US 20030167089A1 · Lane · 2003 [cited by applicant]
US 20030212454A1 · Scott et al. · 2003 [cited by applicant]
US 20040030381A1 · Shu · 2004 [cited by applicant]
US 20040086543A1 · Keogh et al. · 2004 [cited by applicant]
US 20040158320A1 · Simionescu et al. · 2004 [cited by applicant]
US 20050010773A1 · Lapstun et al. · 2005 [cited by applicant]
US 20050119736A1 · Zilla et al. · 2005 [cited by applicant]
US 20050136510A1 · Hendriks et al. · 2005 [cited by applicant]
US 20050211680A1 · Li et al. · 2005 [cited by applicant]
US 20060084957A1 · Delfyett et al. · 2006 [cited by applicant]
US 20060099326A1 · Keogh et al. · 2006 [cited by applicant]
US 20060110370A1 · Pathak et al. · 2006 [cited by applicant]
US 20060159641A1 · Girardot et al. · 2006 [cited by applicant]
US 20060193885A1 · Leonard Neethling et al. · 2006 [cited by applicant]
US 20060210960A1 · Livesey et al. · 2006 [cited by applicant]
US 20060217804A1 · Dove · 2006 [cited by applicant]
US 20060217805A1 · Dove · 2006 [cited by applicant]
US 20070050014A1 · Johnson · 2007 [cited by applicant]
US 20070073392A1 · Heyninck-Jantz et al. · 2007 [cited by applicant]
US 20070203576A1 · Lee et al. · 2007 [cited by applicant]
US 20070254005A1 · Pathak et al. · 2007 [cited by applicant]
US 20080302372A1 · Davidson et al. · 2008 [cited by applicant]
US 20080319166A1 · Shen · 2008 [cited by applicant]
US 20090041729A1 · Wolfinbarger, Jr. et al. · 2009 [cited by applicant]
US 20090130162A2 · Pathak et al. · 2009 [cited by applicant]
US 20090137999A1 · Silberberg et al. · 2009 [cited by applicant]
US 20090188900A1 · Cali et al. · 2009 [cited by applicant]
US 20090254175A1 · Quijano · 2009 [cited by examiner]
US 20090326524A1 · Cali et al. · 2009 [cited by applicant]
US 20100036484A1 · Hariton et al. · 2010 [cited by applicant]
US 20110092966A1 · Guo et al. · 2011 [cited by applicant]
US 20110177150A1 · Pathak et al. · 2011 [cited by applicant]
US 20110214398A1 · Liburd et al. · 2011 [cited by applicant]
US 20110238167A1 · Dove et al. · 2011 [cited by applicant]
US 20110295363A1 · Girard et al. · 2011 [cited by applicant]
US 20110300625A1 · Paniagua et al. · 2011 [cited by applicant]
US 20110306124A1 · Strasly et al. · 2011 [cited by applicant]
US 20110311493A1 · Dove et al. · 2011 [cited by applicant]
US 20110319991A1 · Hariton · 2011 [cited by examiner]
US 20120035720A1 · Cali et al. · 2012 [cited by applicant]
US 20120059487A1 · Cunanan et al. · 2012 [cited by applicant]
US 20120067855A1 · Guo et al. · 2012 [cited by applicant]
US 20120078356A1 · Fish et al. · 2012 [cited by applicant]
US 20120095551A1 · Navia et al. · 2012 [cited by applicant]
US 20120101572A1 · Kovalsky · 2012 [cited by examiner]
US 20120123529A1 · Levi · 2012 [cited by examiner]
US 20120123557A1 · Carpentier et al. · 2012 [cited by applicant]
US 20120185038A1 · Fish et al. · 2012 [cited by applicant]
US 20120328905A1 · Guo et al. · 2012 [cited by applicant]
US 20130122583A1 · Neethling · 2013 [cited by applicant]
US 20130150957A1 · Weber · 2013 [cited by examiner]
US 20130238088A1 · Navia et al. · 2013 [cited by applicant]
US 20140249623A1 · Matheny · 2014 [cited by applicant]
US 20140330370A1 · Matheny et al. · 2014 [cited by applicant]
US 20150088247A1 · L'Heureux et al. · 2015 [cited by applicant]
US 20150094802A1 · Buchbinder · 2015 [cited by examiner]
US 20160175095A1 · Dienno et al. · 2016 [cited by applicant]
US 20160374802A1 · Levi · 2016 [cited by examiner]
US 20170056164A1 · Wang · 2017 [cited by examiner]
US 20170173214A1 · Wang · 2017 [cited by examiner]
US 20180228602A1 · Weber · 2018 [cited by examiner]
US 20180325664A1 · Gonda · 2018 [cited by examiner]
US 20190224369A1 · Rzany · 2019 [cited by examiner]
US 20200060814A1 · Murphy · 2020 [cited by examiner]
US 20200323629A1 · Girard · 2020 [cited by examiner]
US 20200330223A1 · Howard · 2020 [cited by examiner]
US 20210060208A1 · Hoerstrup · 2021 [cited by examiner]
US 20210267755A1 · Wallace · 2021 [cited by examiner]
US 20220023034A1 · Van Der Burgt · 2022 [cited by examiner]
US 20220047385A1 · Gray · 2022 [cited by examiner]
EP 0169259A1 · 1986 [cited by applicant]
EP 2394673A1 · 2011 [cited by applicant]
WO 8401894A1 · 1984 [cited by applicant]
WO 9511047A1 · 1995 [cited by applicant]
WO 9522361A1 · 1995 [cited by applicant]
WO 9534332A1 · 1995 [cited by applicant]
WO 9613227A1 · 1996 [cited by applicant]
WO 9807452A1 · 1998 [cited by applicant]
WO 9843556A1 · 1998 [cited by applicant]
WO 0032252A1 · 2000 [cited by applicant]
WO 2004082536A1 · 2004 [cited by applicant]
WO 2006026325A2 · 2006 [cited by applicant]
WO 2006099334A2 · 2006 [cited by applicant]
WO 2012048035A2 · 2012 [cited by applicant]
WO 2013009851A2 · 2013 [cited by applicant]
WO WO2018102826A1 · 2018 [cited by examiner]
Carpentier, A., et al., “Biological Factors Affecting Long-Term Results of Valvular Heterografts,” Forty-ninth Meeting of the American Association for Thoracic Surgery, San Francisco, CA, Mar. 31-Apr. 2, 1969. [cited by applicant]
Chanda, J., et al., “Heparin in Calcification Prevention of Porcine Pericardial Bioprostheses,” Biomaterials, Elsevier Science Publishers, vol. 18, No. 16, ISSN: 0142-9612, Aug. 1, 1997. [cited by applicant]
Chvapil, M., et al., “Use of Chemically Purified and Cross-Linked Bovine Pericardium as a Ligament Substitute,” Journal of Biomedical Materials Research, vol. 21, No. 12, pp. 1383-1394, 1987, University of Arizona Healt… [cited by applicant]
Dahm, Manfred, et al., “Effects of Surface Seeding with Vital Cells on the Calcium Uptake of Biological Materials for Heart Valve Replacement,” J Heart Valve Dis, vol. 5, No. 2, Mar. 1996, 148-151. [cited by applicant]
Fahner, P., et al., “Systematic Review of Preservation Methods and Clinical Outcome of Infrainguinal Vascular Allografts,” Journal of Vascular Surgery, vol. 44, No. 3, pp. 518-524, 2006. [cited by applicant]
Fumoto, H., et al., “Performance of Bioprosthetic Valves After Glycerol Dehydration, Ethylene Oxide Sterilization, and Rehydration,” Innovations, vol. 6, No. 1, Jan./ Feb. 2011. [cited by applicant]
Grabenwoger, M. et al. “Decreased Tissue Reaction to Bioprosthetic Heart Valve Material after L-glutaimc acid Treatment. A Morphological Study.” J. Biomed Mater. Res. Sep. 1992;26(9):1231-40. [cited by applicant]
Grant, R.A., et al., “The Effects of Irradiation with High Energy Electrons on the Structure and Reactivity of Native and Cross-Linked Collagen Fibres,” J. Cell Sci. vol. 7, 99. 387-405, 1970. [cited by applicant]
Hauschka, P., et al., “Direct Identification of the Calcium- Binding Amino Acid, y-Carboxyglutamate, in Mineralized Tissue,” Proc. Nat. Acad. Sci. vol. 72, No. 10, pp. 3925-3929, Oct. 1975. [cited by applicant]
Jayakrishnan, A., et al., “Glutaraldehyde as a Fixative in Bioprostheses and Drug Delivery Matrices,” Biomaterials, vol. 17, Issue 5, 1996, pp. 471-484. [cited by applicant]
Khora, Eugene, “Methods for the Treatment of Collagenous Tissues for Bioprostheses,” Biomaterials, vol. 18, Issue 2, Jan. 1997, pp. 95-105. [cited by applicant]
Liao, K., et al., “Mechanical Stress: An Independent Determinant of Early Bioprosthetic Calcification in Humans,” Ann. Throac. Surg 2008;86:491-495. [cited by applicant]
Neethling, W., et al., “Enhanced Biostability and Biocompatibility of Decellularized Bovine Pericardium, Crosslinked with an Ultra-Low Concentration Monomeric Aldehyde and Treated with Adapt®,” J. Heart Valve Dis. 2008;… [cited by applicant]
Olde Damink, L.H.H., et al., “Influence of Ethylene Oxide Gas Treatment on the in vitro Degradation Behavior of dermal Sheep Collagen,” Journal of Biomedical Materials Resarch, vol. 29, pp. 149-155, 1995. [cited by applicant]
R Parker, et al. Storage of Heart Valve Allografts in Glycerol With Subsequent Antibiotic Sterilisation, Thorax, 1978, 638-645, vol. 33:5, British Thoracic Society, London, UK. [cited by applicant]
Saegeman, V., et al., “Short and long term bacterial inhibiting effect of high concentrations of glycerol used in the prevention of skin allografts,” Science Direct, Burns, No. 34, Mar. 2008. [cited by applicant]
Schmidt, C., et al., “Acellular Vascular Tissues: Natural Biomaterials for Tissue Repair and Tissue Engineering,” Biomaterials, vol. 21, pp. 2215-2231, 2000. [cited by applicant]
Trantina-Yates AE, et al. “Detoxification of Top Enhanced, Diamine-Extended Glutaraldehyde Fixation Significantly Reduces Bioprosthetic Root Calcification in the Sheep Model,” J. Heart Valve Dis. Jan. 2003; 12 (1):93-10… [cited by applicant]
Zilla, P., et al., “Carbodiimide Treatment Dramatically Potentiates the Anticalcific Effect of Alpha-Amino Oleic Acid on Glutaraldehyde-Fixed Aortic Wall Tissue,” The Annals of Thoracic Surgery, Elsevier, vol. 79, No. 3… [cited by applicant]